| CAS NO: | 228113-66-4 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 250mg | 电议 |
Maralixibat chloride (SHP625; LUM001; SHP-625; LUM-001; lopixibat; Livmarli) is a potent ileal bile acid transporter inhibitor that has gained FDA approval in 2021 for treatment of cholestatic pruritus associated with Alagille syndrome.
纯度：≥98%
CAS：228113-66-4
m.cnreagent.com